Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Gross Margin (2012 - 2026)

Exelixis (EXEL) posted quarterly Gross Margin of 96.73% for Q2 2026, up 18.0% year-over-year from 81.98% in Q2 2025, and up 1.21% quarter-over-quarter from 95.58% in Q1 2026.

Analysis

Exelixis (EXEL) Gross Margin (2012 - 2026) Analysis & Trends

Exelixis' Gross Margin history runs 15 years deep, the most recent figure standing at 96.73% for Q2 2026.

  • In Q2 2026, Gross Margin rose 18.0% year-over-year to 96.73%; the TTM figure through Apr 2026 stood at 96.44% (down 33.0% YoY), while the FY2026 annual figure was 96.39%, down 9.0% from the prior year.
  • Gross Margin for Q2 2026 stood at 96.73%, up from 95.58% in the prior quarter.
  • The five-year high for Gross Margin was 97.23% in Q2 2024, with the low at 95.0% in Q1 2024.
  • The 5-year median for Gross Margin is 96.48% (2025), against an average of 96.33%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin plunged 150 bps in 2024, then surged 155 bps in 2025.
  • Exelixis' Gross Margin stood at 96.24% in 2022, then slipped by 1 bps to 95.46% in 2023, then climbed by 1 bps to 96.79% in 2024, then rose by 0 bps to 96.89% in 2025, then dropped by 0 bps to 96.73% in 2026.
  • Business Quant data shows EXEL's Gross Margin at 96.73% in Q2 2026, 95.58% in Q1 2026, and 96.89% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 91.59%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 90.43%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 35.86%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 89.76%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 76.90%
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 84.20%
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 96.71%
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 96.71%
Apr 3, 2026 96.73%
Jan 2, 2026 95.58%
Oct 3, 2025 96.89%
Jul 4, 2025 96.57%
Apr 4, 2025 96.55%
Jan 3, 2025 96.48%
Sep 27, 2024 96.79%
Jun 28, 2024 97.23%
Mar 29, 2024 95.00%
Dec 29, 2023 95.46%
Sep 29, 2023 96.02%
Jun 30, 2023 96.23%
Mar 31, 2023 96.50%
Dec 30, 2022 96.24%
Sep 30, 2022 96.28%
Jul 1, 2022 96.79%
Apr 1, 2022 96.29%
Oct 1, 2021 96.38%
Jul 2, 2021 96.14%